Source-ELRIG
Introduction to ELRIG UK Conference
ELRIG UK, the European Laboratory Research & Innovation Group, has announced the keynote speakers for its upcoming Research and Innovation conference scheduled to be held at the University of Manchester from March 20–21. The event aims to accelerate drug discovery by bringing together experts, scientists, researchers, and entrepreneurs to discuss emerging biology and innovative technologies shaping the future of therapeutics. This year’s conference will focus on key topics such as animal-free technologies, oncology drug discovery, antimicrobial resistance, and advancements in mass spectrometry techniques and proteomics.
Keynote Speakers and Their Contributions
The conference will feature two distinguished keynote speakers: Steve Bates OBE FMedSci, CEO of the BioIndustry Association (BIA), and Dr. Anderson Ryan, Co-founder and Head of R&D and Drug Development at FasT BioPharma. Steve Bates is a renowned advocate for innovation in the life sciences sector, leading the BIA in promoting collaboration between industry, research charities, and academia. His extensive experience in both the private and public sectors, including roles with Genzyme and advisory positions in the UK government, underscores his commitment to advancing the life sciences landscape.
Dr. Anderson Ryan, with a background in oncology research and drug development, brings valuable expertise in translating scientific discoveries into therapeutic interventions. His contributions to oncology research, including work at AstraZeneca and as a lecturer at the University of Manchester, highlight his dedication to advancing cancer treatment.
Exciting Additions and Perspectives on the Event
In addition to the keynote presentations, ELRIG will introduce the TechBio Breakthrough Zone at the Research and Innovation 2024 conference. This new exhibition space provides opportunities for emerging companies to showcase their technologies and engage with potential partners and customers. Furthermore, ELRIG will recognize early-career professionals through the Impact Award, acknowledging their scientific contributions to early-stage drug discovery. Conference directors Sarah Brockbank and Roger Clark express their enthusiasm for the event, emphasizing the importance of collaboration and innovation in driving drug discovery forward. Steve Bates and Dr. Anderson Ryan share their excitement about speaking at the conference, highlighting the valuable networking and learning opportunities it offers to the life sciences community.
Overall, the ELRIG UK Research and Innovation 2024 conference promises to be a dynamic platform for fostering collaboration, sharing insights, and exploring cutting-edge technologies in drug discovery and development. With an impressive lineup of speakers and engaging sessions, the event is poised to inspire breakthroughs and advancements in the field of life sciences.
